BIG PHARMA EARNINGS WATCH: NOVARTIS, MERCK, GLAXO SMITH KLINE, BRISTOL-MYERS SQUIBB
New Q3 Earnings Reports Underscore How Price Hikes, Anti-Competitive Tactics… Read More
New Q3 Earnings Reports Underscore How Price Hikes, Anti-Competitive Tactics… Read More
First Round of Q3 Earnings Reports Show Big Pharma Companies Raking in Big… Read More
Broad Array of Leaders Encourage Lawmakers to Capitalize on Unprecedented… Read More
Remembering Drug Companies Spend Their Profits on Shareholders and Marketing… Read More
Q2 Earnings Reports Continue to Show Pandemic Price Hikes Profitable for Brand… Read More
Big Pharma Companies Continue to Rake in Massive Profits After Three Rounds of… Read More
New Round of Earnings Reports Show Big Pharma Companies Riding High on Massive… Read More
Big Pharma Wants Implementation of Misguided Policy that Does Nothing to Lower… Read More
Lawmakers Showcase How Big Pharma’s Patent Abuse Drives Out-of-Control… Read More
U.S. Senate Judiciary Subcommittee Hearing Tuesday Will Build on Momentum for… Read More
Brand Name Drug Companies Stick to Business-as-Usual in Third Major Round of… Read More
Coverage Highlights Backlash Over Massive Price Tag for Unproven Treatment,… Read More